Gene of the month: SMARCB1

Stains & CD markers INI1 / SMARCB1

SMARCB1-deficient Tumors of Childhood: A Practical Guide

SMARCB1/INI1-deficient tumors of adulthood

Immunotherapy for SMARCB1-deficient sarcomas: current evidence and future developments 

Emerging role of SWI/SNF complex deficiency as a target of immune checkpoint blockade in human cancers

Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy

SWI/SNF-deficient Malignancies: Optimal Candidates for Immune-oncological Therapy?

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas

Epigenetic Combination Therapy Could Overcome Treatment Resistance in Epithelioid Sarcomas and Rhabdoid Tumors

SWI/SNF complex-deficient soft tissue neoplasms: An update

SWI/SNF Chromatin Remodeling and Human Malignancies

The SWI/SNF complex in cancer – biology, biomarkers and therapy

Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies

Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors